Preoperative survivin, ERCC1, and PTEN expression in stage III non-small cell lung cancer (NSCLC) patients (pts) treated with neoadjuvant and definitive chemoradiation and association with overall survival (OS)

被引：0
|
作者：
Batus, Marta [1 ]
Fidler, Mary J. [1 ]
Walters, Kelly Kaiser [1 ]
Pool, Mark [1 ]
Mahon, Brett [1 ]
Basu, Sanjib [1 ]
Borgia, Jeffrey Allen [1 ]
Sher, David [1 ]
Bonomi, Philip D. [1 ]
机构：
[1] Rush Univ, Med Ctr, Chicago, IL 60612 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7067
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Prognostic and predictive role of ERCC1 protein expression in locally advanced stage III non-small cell lung cancer
    Sad, Lamiss Mohamed
    Younis, Samar Galal
    Elity, Mohamed Mosad
    MEDICAL ONCOLOGY, 2014, 31 (07)
  • [32] Comparison of PD-L1 expression before and after neoadjuvant chemoradiation or chemotherapy in stage III non-small cell lung cancer (NSCLC)
    Koenig, D.
    Prince, S. Savic
    Trachsel, B.
    Hayoz, S.
    Pless, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S1376 - S1376
  • [33] SEQUENTIAL CHEMORADIATION AND RADIATION ALONE IN THE TREATMENT OF INOPERABLE, LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) AND CORRELATION OF TUMOUR ERCC1 WITH SURVIVAL
    Davda, R.
    Griffith, J. S. G.
    Smith, D.
    Makker, H.
    Read, G. A.
    Ward, D.
    Sundaresan, V.
    Falzon, M.
    Singer, J. M.
    LUNG CANCER, 2009, 64 : S46 - S46
  • [34] Association between hospital volume, treatment patterns, and overall survival (OS) of patients with stage 3A non-small cell lung cancer (NSCLC).
    Tella, Harsha
    Kommalapati, Anuhya
    Ganti, Apar Kishor
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [35] ERCC1 protein expression is not associated with survival after platinum-based chemotherapy in patients with metastatic non-small cell lung cancer (NSCLC)
    Pennell, Nathan A.
    Chirieac, Lucian R.
    El Karak, Fadi
    Lynch, Thomas J.
    Heist, Rebecca S.
    Christiani, David C.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (06) : S238 - S239
  • [36] ERCC1 MRNA EXPRESSION AND RESPONSE TO CISPLATIN-DOCETAXEL NEOADJUVANT CHEMOTHERAPY IN NON-SMALL CELL LUNG CANCER PATIENTS
    Consito, L.
    Buffoni, L.
    Grillo, R.
    Paze, E.
    Barone, C.
    Dongiovanni, D.
    Cristiano, C.
    Birocco, N.
    Ciuffreda, L.
    Schena, M.
    ANNALS OF ONCOLOGY, 2009, 20
  • [37] Effect of ERCC1 polymorphisms and the modification by smoking on the survival of non-small cell lung cancer patients
    Park, So-Yeon
    Hong, Yun-Chul
    Kim, Jin-Hee
    Kwak, Seung-Min
    Cho, Jae-Hwa
    Lee, Hong-Lyeol
    Ryu, Jeong-Seon
    MEDICAL ONCOLOGY, 2006, 23 (04) : 489 - 498
  • [38] ERCC1 as a predictor of response to induction therapy for stage III non-small cell lung cancer.
    Marra, Alessandro
    Kemming, Dirk
    Krueer, Thomas
    Bosse, Ulrich
    Netchaeva, Maria
    Wagner, Wolfgang
    Koch, Olaf M.
    Vogt, Ulf
    Hillejan, Ludger
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [39] ERCC1 and RRM1 but not EGFR gene expression is predictive of shorter survival in advanced non-small cell lung cancer (NSCLC).
    Selvaggi, G.
    Ceppi, P.
    Volante, M.
    Saviozzi, S.
    Novello, S.
    Calogero, R.
    Papotti, M.
    Scagliotti, G. V.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 548S - 548S
  • [40] Effect of ERCC1 polymorphisms and the modification by smoking on the survival of non-small cell lung cancer patients
    So-Yeon Park
    Yun-Chul Hong
    Jin-Hee Kim
    Seung-Min Kwak
    Jae-Hwa Cho
    Hong-Lyeol Lee
    Jeong-Seon Ryu
    Medical Oncology, 2006, 23 : 489 - 498
12345